ArticleMolecular and clinical oncology2019

Tolerability and safety of real-world use of pomalidomide in patients with relapsed/refractory multiple myeloma.

Eiseki Usami et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.